In conclusion, in this study we provide a mechanism for C-Myb-mediated cisplatin resistance of ovarian cancer cells that involves downregulated lncRNA NKILA, activated NF-κB signaling, increased stemness marked by LIN28A and the resulting downregulated let-7 family of miRNAs. The gene discussed is NKILA; the disease is ovarian carcinoma.